DEC 14, 2016 07:30 AM PST

Advances in modeling human diseases using induced pluripotent stem cell-derived cellular models

Speakers
  • Field Application Scientist; Cellular Dynamics
    Biography
      T.K. Feaster, PhD, is a Field Application Scientist at Cellular Dynamics International (CDI; Madison, WI), a Fujifilm company. Dr. Feaster received his PhD in Pharmacology in 2015 from Vanderbilt University for his work using human induced pluripotent stem cell-derived cardiomyocytes to investigate cardiac excitation-contraction coupling. Dr. Feaster joined CDI as a Technical Application Scientist working in the applications group where he served as the primary support liaison for cardiac products, as well as sharing responsibility for in-lab application development. He is currently a Field Application Scientist for CDI's Toxicology and Safety Pharmacology business unit.
    • Applications Scientist; Cellular Dynamics
      Biography
        Kile P. Mangan, PhD, an Applications Scientist at CDI, achieved Bachelor degrees in both Physiological Psychology and Philosophy (2000), followed by a PhD in Neuroscience (2013) from the University of Wisconsin - Madison. Dr. Mangan previously worked at Kimberly-Clark Corp., Rush Medical Center and University of Wisconsin School of Medicine. Dr. Mangan's PhD thesis work centered on a genetic absence (R43Q) epilepsy, discovering that tonic inhibitory currents were abolished within excitatory principle cortical neurons via a mutation-induced GABAergic receptor-trafficking alteration. His research further uncovered a novel, synthetic steroid treatment to re-establish the lost tonic inhibition, thereby decreasing absence seizure episode number and severity. At CDI, his work includes all aspects of CDI's neuronal products, including electrophysiological behaviors and measurements. Dr. Mangan's evaluation on neural-network integration and maturation within iPSC-derived neuronal cultures has helped push the field of MEA analysis and pharmacological screening forward to ‘disease-in-a-dish' assays.

      Abstract:

      DATE: December 14, 2016
      TIME: 7:30am PT, 10:30am ET

      A major hurdle in developing relevant disease models for drug discovery is access to the healthy and diseased tissue of interest; induced pluripotent stem cell (iPSC) technology addresses this problem affording access to biologically relevant human tissues in essentially unlimited quantities. In this webinar, we will describe examples of how iPSC-derived disease cell models can be used to understand pathophysiological pathways in disease. Among the examples we will highlight are models of diseases induced in iPSC-derived cells from a healthy background; of epilepsy, Alzheimer’s and Parkinson’s diseases engineered into a healthy background; and of monogenic and idiopathic patient-derived models for cardiac diseases. We will briefly touch on current efforts aimed at generating large iPSC clone banks from disease backgrounds that will serve to expand access to human cell-based models. These human cell-based models can be used to explore the pathological phenotypes, genotype phenotype relationships, and environmental influences on a disease.


      Show Resources
      You May Also Like
      MAY 22, 2018 08:00 AM PDT
      C.E. CREDITS
      MAY 22, 2018 08:00 AM PDT
      DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
      MAY 24, 2018 09:30 AM PDT
      C.E. CREDITS
      MAY 24, 2018 09:30 AM PDT
      DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
      MAY 03, 2018 11:00 AM PDT
      MAY 03, 2018 11:00 AM PDT
      DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
      APR 27, 2018 10:00 AM PDT
      C.E. CREDITS
      APR 27, 2018 10:00 AM PDT
      DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
      JUN 29, 2018 09:00 AM PDT
      C.E. CREDITS
      JUN 29, 2018 09:00 AM PDT
      DATE: June 29, 2018TIME: 09:00AM PDT, 12:00PM EDT There is significant epidemiological evidence to suggest that the consumption of a high-broccoli diet is associated with a r...
      JUL 20, 2017 10:00 AM PDT
      JUL 20, 2017 10:00 AM PDT
      DATE: July 20, 2017TIME: 10:00am PT, 1:00pm ETPart 1 - Daniel Beacham: Case study showing how CyQUANT Direct Cell Proliferation and Fluo-4 calcium imaging assays were us...
      Loading Comments...